Serum homocysteine levels and cognitive functioning in euthymic bipolar patients

Journal of Affective Disorders

Volumn 113, Issue 3, 2009, Pages 285-290

  Dias, Vasco Videira ^a,d,e   Brissos, Sofia ^b,d,e   Cardoso, Carlos ^c,d,e   Andreazza, Ana Cristina ^c,d,e   Kapczinski, Flávio ^d,e  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Centro Hospitalar de Lisboa Central   (Portugal)

^c Laboratory Dr Joaquim Chaves   (Portugal)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cognition; Folate; Homocysteine; Neurocognitive performance; Psychosocial; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BIPOLAR I DISORDER; CIGARETTE SMOKING; COGNITION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; FOLIC ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; VITAMIN BLOOD LEVEL;

ADULT; AGE FACTORS; BIPOLAR DISORDER; COGNITION DISORDERS; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIC DISORDER; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; VITAMIN B 12;

EID: 58749104984     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.05.011     Document Type: Article

References (23)

1. Algaidi S.A., Christie L.A., Jenkinson A.M., Whalley L., Riedel G., and Platt B. Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signaling and synaptic plasticity. Exp. Neurol. 197 (2006) 8-21
2. American Psychiatric Association. Diagnostic and Statistic Manual of Mental Disorders: DSM-IV (1994), Washington, DC.
3. Boulander-Gouaille, C., 2000. Focus on homocysteine. Springer Verlag, France.
4. Daban C., Amado I., Bourdel M.-C., Loo H., Olie J.-P., Poirier M.-F., and Krebs M.O. Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J. Psychiatry Res. 39 (2005) 391-398
5. Dittmann S., Seemuller F., Schwartz M.J., Kleindienst N., Stampfer R., Zach J., Born C., Bernhard B., Fast K., Grunze H., Engel R.R., and Severus E. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord. 9 (2007) 63-70
6. Dittmann S., Seemüller F., Grunze H.C., Schwarz M.J., Zach J., Fast K., Born C., Dargel S., Engel R.R., Bernhard B., Möller H.J., Riedel M., and Severus W.E. The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. J. Clin. Psychiatry 69 (2008) 899-906
7. Endicott S., Spitzer L., Fleiss J.L., and Cohen S. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33 (1976) 766-771
8. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
9. Levine J., Stahl Z., Sela B.A., Ruderman V., Shumaico O., Babushkin I., Osher Y., Bersudsky Y., and Belmaker R.H. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol. Psychiatry 60 (2006) 265-269
10. Lezak M., Howienson D., Loring D., Hannay H., and Fischer J. Neuropsychological Assessment. (2004), Oxford University Press, Oxford
11. Lyoo I.K., Sung Y.H., Dager S.R., Friedman S.D., Lee J.Y., Kim S.J., Kim N., Dunner D.L., and Renshaw P.F. Regional cerebral cortical thinning in bipolar disorder. Bipolar. Disord. 8 (2006) 65-74
12. Martinez-Arán A., Vieta E., Colom F., Torrent C., Reinares M., Goikolea J.M., Benabarre A., and Sanchez-Moreno J. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment?. Psychother. Psychosom. 74 (2005) 295-302
13. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 9 (1971) 97-113
14. Osher Y., Sela B.A., Levine J., and Belmaker R.H. Elevated homocysteine levels in euthymic bipolar disorder patients showing functional deterioration. Bipolar. Disord. 6 (2004) 82-86
15. Osher Y., Bersudsky Y., Silver H., Sela B.A., and Belmaker R.H. Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. J. Affect. Disord. 105 (2008) 229-233
16. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., and Licastro F. Homocysteine and folate as risk factors for dementia and Alzheimer's disease. Am. J. Clin. Nutr. 82 (2005) 636-643
17. Reif A., Pfuhlmann B., and Lesch K.P. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog. Neuropsychopharmacol. Biol. Psychiatry. 29 (2005) 1162-1168
18. Refsum H., Smith A.D., Ueland P.M., Nexo E., Clarke R., McPartlin J., Johnston C., Engbaek F., Schneede J., McPartlin C., and Scott J.M. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem. 50 (2004) 3-32
19. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002) 476-483
20. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. Suppl 20 (1998) 22-33 quiz 34-57
21. Strauss E., Sherman E., and Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. 3rd ed. (2006), Oxford University Press, New York
22. Torres I.J., Boudreau V.G., and Yatham L.N. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta. Psychiatry. Scand. Suppl. 434 (2007) 17-26
23. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry. 133 (1978) 429-435